Phytopharmaceutical Lead for the Management of Mild Cognitive Impairment (MCI) Including Alzheimer's disease

Crocus sativus based phytopharmaceutical product for the management of Mild Cognitive Impairment (MCI) including Alzheimer's disease (AD). It contains 20% of total crocins. It Induced Aβ-BEI (clearance across the BBB) and induced the expression of BBB-Aβ clearance proteins. It Showed anti-dementia properties, by significant improvement in STZ induced memory deficit in Morris Water Maze test in rats
It also improved memory, learning in Rat models, while showing Good Safety Profile .

To be employed for the management of MCI including Alzheimer's disease.

Novel Phytopharmaceutical Formulation for the management of the MCI including Alzheimer disease.